Published May 10, 2022
| Version v1
Report
Open
Malaria chemoprevention and drug resistance
Authors/Creators
- 1. University of Maryland School of Medicine, Baltimore, United States of America
Description
This report was considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2 Preventive chemotherapies” of the WHO Guidelines for malaria, 3 June 2022.
Notes
Review subsequently published on 24 March 2022 in Malaria Journal: https://doi.org/10.1186/s12936-022-04115-8